Drug Development

Podcast: Insights from CDO Experts from Samsung Biologics

Jiyeon Lee; Hyelyoung Jang

Samsung Biologics

CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.

Wheeler Bio

Cell Line Development Technology

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

Wheeler Bio

Cell Line Development

Integrating Cell Line and CMC Development

Stephen Hamilton, Ph.D.; Mike Brem

Wheeler Bio

Cell Line Development

Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow

Advanced Instruments

Capacity Expansion

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand

Richter-Helm BioLogics

Cell Line Development

Rising Demand for Novel Cancer Treatment Approaches to Propel Cell Line Development Market through 2024

Global Market Insights

Strategic Collaboration

Berkeley Lights and TPG Biologics Enter into a Strategic Collaboration for Cell Line Development

Berkeley Lights